HARPOON THERAPEUTICS
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct (TriTAC), platform, Harpoon is developing a pipeline of novel T cell engagers, or TriTACs, initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon's first drug candidate, HPN424, is currently in Phase 1 clinical trial as a treatment for prostate cancer.
HARPOON THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.harpoontx.com
Total Employee:
51+
Status:
Active
Contact:
650-443-7400
Total Funding:
130 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache Microsoft Exchange Online
Similar Organizations
Aletheia Therapeutics
Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer.
amcure
amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer.
Atara Biotherapeutics
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Atsena Therapeutics
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
GamaMabs Pharma
GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.
Inspyr Therapeutics
Inspyr Therapeutics is a clinical stage company focused on novel targeted precision therapeutics for the treatment of cancer.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Guided Therapeutics
Guided Therapeutics is a medical technology company developing biophotonics solutions for the non-invasive detection of cancer.
Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Kurome Therapeutics
Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.
Marker Therapeutics
Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Sierra Oncology
Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.
Valanbio Therapeutics
Valanbio Therapeutics is an early-stage anti-infectives company that develops novel antibiotics for Gram-negative organisms.
Current Advisors List
Board_member
2017-05-01
Board_member
2017-05-01
Board_member
2015-01-01
Board_member
2018-08-01
Board_member
2016-01-01
Board_member
2018-12-01
Board_member
2015-01-01
Current Employees Featured
Gerald McMahon President & CEO @ Harpoon Therapeutics
President & CEO
2016-12-01
Georgia Picht CFO @ Harpoon Therapeutics
CFO
Luke Evnin Co-Founder @ Harpoon Therapeutics
Co-Founder
Susan D. Jones Senior Vice President, Product Development @ Harpoon Therapeutics
Senior Vice President, Product Development
2017-06-01
Che-Leung Law Vice President @ Harpoon Therapeutics
Vice President
Georgia Erbez Chief Financial Officer @ Harpoon Therapeutics
Chief Financial Officer
2018-10-01
Natalie Sacks Chief Medical Officer @ Harpoon Therapeutics
Chief Medical Officer
2018-10-01
Julie Eastland Chief Executive Officer @ Harpoon Therapeutics
Chief Executive Officer
2021-11-01
Holger Wesche SENIOR VICE PRESIDENT @ Harpoon Therapeutics
SENIOR VICE PRESIDENT
Founder
Stock Details
Investors List
MPM Capital
MPM Capital investment in Series C - Harpoon Therapeutics
UBS Asset Management
UBS Asset Management investment in Series C - Harpoon Therapeutics
OrbiMed
OrbiMed investment in Series C - Harpoon Therapeutics
oncology impact fund
oncology impact fund investment in Series C - Harpoon Therapeutics
NS Investment
NS Investment investment in Series C - Harpoon Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series C - Harpoon Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - Harpoon Therapeutics
Ridgeback Capital
Ridgeback Capital investment in Series C - Harpoon Therapeutics
Arix Bioscience
Arix Bioscience investment in Series C - Harpoon Therapeutics
Taiho Ventures
Taiho Ventures investment in Series C - Harpoon Therapeutics
Official Site Inspections
http://www.harpoontx.com Semrush global rank: 3.44 M Semrush visits lastest month: 4.46 K
- Host name: ad8242ffdb37e18fd.awsglobalaccelerator.com
- IP address: 75.2.16.51
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Harpoon Therapeutics"
Harpoon Therapeutics | Immuno-oncology | TriTACâ„¢
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of …See details»
Harpoon Therapeutics - Crunchbase Company Profile …
Contact Email bd@harpoontx.com Phone Number 650-443-7400 Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system …See details»
Harpoon Therapeutics - Overview, News & Similar companies
Dec 26, 2023 Who is Harpoon Therapeutics. Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power …See details»
Merck to Acquire Harpoon Therapeutics, Further …
Jan 8, 2024 For additional information about Harpoon Therapeutics, please visit www.harpoontx.com. About Merck. At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the …See details»
Harpoon Therapeutics - Company Profile & Staff Directory
Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering …See details»
Harpoon Therapeutics - LinkedIn
Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering …See details»
Harpoon Therapeutics
Dec 14, 2024 Harpoon Therapeutics was founded in 2015 by Dario Ghersi, M.D. and Peter Van Vlasselaer, Ph.D., and has since become a global leader in the field of novel bispecific …See details»
Harpoon Therapeutics Expands Leadership Team - GlobeNewswire
Jul 6, 2022 Appointments named for two key executive leadership positions in human resources and translational medicine SOUTH SAN FRANCISCO, Calif., July 06, 2022 ...See details»
Harpoon Therapeutics Strengthens Leadership Team
Dec 26, 2023 In his current role at Harpoon, Mr. Bucher is tasked with leading all legal aspects of the organization, including corporate governance, intellectual property, and compliance …See details»
About Harpoon Therapeutics - pharmiweb.jobs
Jan 9, 2024 Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T-cell engagers designed to harness the power of the body’s immune system to …See details»
Harpoon Therapeutics Announces Change to Management Team …
Oct 26, 2021 Julie Eastland Appointed President and Chief Executive Officer Jerry McMahon, Ph.D., Resigns from Harpoon as President and Chief Executive Officer Scott Myers, Current …See details»
Harpoon Therapeutics Strengthens Leadership Team - Yahoo …
Dec 26, 2023 James Bucher, J.D. joins as Chief Legal Officer Wendy Chang promoted to Chief People Officer SOUTH SAN FRANCISCO, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- …See details»
Harpoon Therapeutics, Inc. - Cruelty Free Investing
Company Website: https://www.harpoontx.com Contact: media@harpoontx.com ©2024 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»
Portfolio company Harpoon Therapeutics to be acquired by Merck …
Jan 8, 2024 The announcement can be accessed on Harpoon Therapeutics’ website at: www.harpoontx.com and the full text of the announcement from the company is contained …See details»
Merck to Acquire Harpoon Therapeutics, Further Diversifying …
Jan 8, 2024 RAHWAY, N.J. & SOUTH SAN FRANCISCO, Calif., January 08, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Harpoon …See details»
Portfolio company Harpoon Therapeutics to be acquired by Merck …
Jan 8, 2024 For additional information about Harpoon Therapeutics, please visit www.harpoontx.com. About Merck . At Merck, known as MSD outside of the United States and …See details»
Harpoon Therapeutics Presents Preclinical Data for TriTAC-XR
Apr 12, 2022 Harpoon Therapeutics, Inc. Georgia Erbez Chief Financial Officer650-443-7400media@harpoontx.com. ICR Westwicke Robert H. Uhl Managing Director858-356-5932 …See details»
What can we help you find? - MSD
Jan 8, 2024 For additional information about Harpoon Therapeutics, please visit www.harpoontx.com. About MSD. At MSD, known as Merck & Co., Inc., Rahway, N.J., USA in …See details»
Harpoon Therapeutics Inc - WhaleWisdom.com
Harpoon Therapeutics, Inc. engages in the development of a novel class of T cell engagers that harness the power of the body's immune system. The company develops tri-specific T cell …See details»
Texas border town wins $13M grant for environment work - The …
2 days ago Presidio, northwest of Big Bend National Park, will get dedicated green spaces along bike lanes and pedestrian streets, plant thousands of native trees and establish a high-school …See details»